These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 1905550
1. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity. Fischer B, Zacharias U, Will H. Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550 [Abstract] [Full Text] [Related]
2. Characterization of human tissue-type plasminogen activator with monoclonal antibodies: mapping of epitopes and binding sites for fibrin and lysine. Zacharias U, Fischer B, Noll F, Will H. Thromb Haemost; 1992 Jan 23; 67(1):88-94. PubMed ID: 1377416 [Abstract] [Full Text] [Related]
3. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH, Nieuwenbroek NM, Verheijen JH. Protein Eng; 1995 Dec 23; 8(12):1295-1302. PubMed ID: 8869642 [Abstract] [Full Text] [Related]
4. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments. de Munk GA, Caspers MP, Chang GT, Pouwels PH, Enger-Valk BE, Verheijen JH. Biochemistry; 1989 Sep 05; 28(18):7318-25. PubMed ID: 2510823 [Abstract] [Full Text] [Related]
5. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin. Fischer B. Biomed Biochim Acta; 1991 Sep 05; 50(1):47-54. PubMed ID: 1830477 [Abstract] [Full Text] [Related]
6. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. Grailhe P, Nieuwenhuizen W, Anglés-Cano E. Eur J Biochem; 1994 Feb 01; 219(3):961-7. PubMed ID: 8112348 [Abstract] [Full Text] [Related]
7. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416. Petersen LC, Boel E, Johannessen M, Foster D. Biochemistry; 1990 Apr 10; 29(14):3451-7. PubMed ID: 2112946 [Abstract] [Full Text] [Related]
8. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator. Fischer BE, Will H. Biochim Biophys Acta; 1990 Oct 18; 1041(1):48-54. PubMed ID: 2145980 [Abstract] [Full Text] [Related]
9. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. van Zonneveld AJ, Veerman H, Pannekoek H. J Biol Chem; 1986 Oct 25; 261(30):14214-8. PubMed ID: 3021732 [Abstract] [Full Text] [Related]
10. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. Wilhelm OG, Jaskunas SR, Vlahos CJ, Bang NU. J Biol Chem; 1990 Aug 25; 265(24):14606-11. PubMed ID: 2117612 [Abstract] [Full Text] [Related]
11. Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies. Holvoet P, Lijnen HR, Collen D. Eur J Biochem; 1986 Jul 01; 158(1):173-7. PubMed ID: 3089776 [Abstract] [Full Text] [Related]
12. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis. Weening-Verhoeff EJ, Quax PH, van Leeuwen RT, Rehberg EF, Marotti KR, Verheijen JH. Protein Eng; 1990 Dec 01; 4(2):191-8. PubMed ID: 1963688 [Abstract] [Full Text] [Related]
13. Monoclonal antibody interferes with fibrin binding of t-PA. Matsuo O, Okada K, Fukao H, Tanaka N, Ueshima S. Thromb Res; 1988 Sep 01; 51(5):485-94. PubMed ID: 2459803 [Abstract] [Full Text] [Related]
14. Comparison of fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator (t-PA) and fibrin-dependent enhancement of amidolytic activity of t-PA. Fischer BE. Blood Coagul Fibrinolysis; 1992 Apr 01; 3(2):197-204. PubMed ID: 1606292 [Abstract] [Full Text] [Related]
15. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. J Clin Invest; 1989 Aug 01; 84(2):647-55. PubMed ID: 2503541 [Abstract] [Full Text] [Related]
16. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator. Bakker AH, Rehberg EF, Marotti KR, Verheijen JH. Protein Eng; 1995 Mar 01; 8(3):293-300. PubMed ID: 7479691 [Abstract] [Full Text] [Related]
17. Binding of tissue-plasminogen activator to fibrin: effect of ultrasound. Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. Blood; 1998 Mar 15; 91(6):2019-25. PubMed ID: 9490686 [Abstract] [Full Text] [Related]
18. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin]. Orbe J, Montes R, Chordá C, Páramo JA, Rocha E. Sangre (Barc); 1994 Aug 15; 39(4):261-6. PubMed ID: 7985055 [Abstract] [Full Text] [Related]
19. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator. Bakker AH, van der Greef W, Rehberg EF, Marotti KR, Verheijen JH. J Biol Chem; 1993 Sep 05; 268(25):18496-501. PubMed ID: 8395505 [Abstract] [Full Text] [Related]
20. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin. Soeda S, Kakiki M, Shimeno H, Nagamatsu A. Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]